Literature DB >> 12742629

Blockade of central histaminergic H2 receptors facilitates catecholaminergic metabolism and aggravates ischemic brain damage in the rat telencephalon.

Ryu Otsuka1, Naoto Adachi, Gen Hamami, Keyue Liu, Toshihiro Yorozuya, Tatsuru Arai.   

Abstract

Blockade of central H(2) receptors aggravates ischemic neuronal damage. Since changes in the activity of the monoaminergic system are contributing factors in the development of ischemic neuronal damage, the authors evaluated the effects of ranitidine on the monoaminergic system and ischemic neuronal damage in the middle cerebral artery (MCA) occlusion model of rats. Wistar rats pretreated with saline or ranitidine (3 and 30 nmol, i.c.v.) were subjected to reversible occlusion of MCA for 2 h. The total infarct volume was determined 24 h after reperfusion. The relationship between dopaminergic activity and the histologic outcome was estimated by lesioning the substantia nigra 2 days before MCA occlusion. In a second experiment, the animals were subjected to 15 min of MCA occlusion, and the effects of ranitidine on the histologic outcome was evaluated 7 days after ischemia. In a third experiment, the tissue concentrations of monoamines and their metabolites were determined in the cerebral cortex and striatum 2 h after reperfusion following MCA occlusion for 2 h. The turnover of norepinephrine and dopamine was compared between animals treated with saline and those treated with ranitidine by estimating the alpha-methyl-p-tyrosine-induced depletion of norepinephrine and dopamine, respectively. The turnover of 5-hydroxytryptamine was evaluated by the probenecid-induced accumulation of 5-hydroxyindoleacetic acid. Treatments with ranitidine markedly increased the infarct volume 24 h after reperfusion. Ranitidine also aggravated delayed neuronal death 7 days after ischemia. The aggravation was abolished by the lesion of the substantia nigra before MCA occlusion. The MCA occlusion increased the turnover of cortical norepinephrine and striatal dopamine. The turnover was further facilitated by ranitidine. Although ranitidine suppressed the 5-hydroxytryptamine turnover in the cerebral cortex, the extent of this effect was similar in both the ischemic and non-ischemic sides. These results suggest that facilitation of the catecholaminergic systems is involved in the aggravation of ischemic neuronal damage by H(2) blockade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742629     DOI: 10.1016/s0006-8993(03)02558-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells.

Authors:  Pengxiang Zhu; Ryuji Hata; Masahito Ogasawara; Fang Cao; Kenji Kameda; Kohei Yamauchi; Alfred H Schinkel; Kazutaka Maeyama; Masahiro Sakanaka
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

2.  Histidine provides long-term neuroprotection after cerebral ischemia through promoting astrocyte migration.

Authors:  Ru-jia Liao; Lei Jiang; Rong-rong Wang; Hua-wei Zhao; Ying Chen; Ya Li; Lu Wang; Li-Yong Jie; Yu-dong Zhou; Xiang-nan Zhang; Zhong Chen; Wei-wei Hu
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.